Post-marketing surveillance for the safety of the 9-valent human papillomavirus vaccine: a retrospective real-world study in China

Please use this identifier to cite or link to this item: https://doi.org/10.1080/14760584.2023.2239911

DC Field	Value
dc.title	Post-marketing surveillance for the safety of the 9-valent human papillomavirus vaccine: a retrospective real-world study in China
dc.contributor.author	Ruogu Meng
dc.contributor.author	Rui Ma
dc.contributor.author	Jianmei Wang
dc.contributor.author	Peipei Liu
dc.contributor.author	Zuoxiang Liu
dc.contributor.author	Bingjie He
dc.contributor.author	Zhike Liu
dc.contributor.author	Yu Yang
dc.contributor.author	Siyan Zhan
dc.date.accessioned	2024-01-18T09:43:49Z
dc.date.available	2024-01-18T09:43:49Z
dc.date.issued	2023-07-27
dc.identifier.citation	Ruogu Meng, Rui Ma, Jianmei Wang, Peipei Liu, Zuoxiang Liu, Bingjie He, Zhike Liu, Yu Yang, Siyan Zhan (2023-07-27). Post-marketing surveillance for the safety of the 9-valent human papillomavirus vaccine: a retrospective real-world study in China. Expert Review of Vaccines 22 (1) : 696-703. ScholarBank@NUS Repository. https://doi.org/10.1080/14760584.2023.2239911
dc.identifier.issn	1476-0584
dc.identifier.uri	https://scholarbank.nus.edu.sg/handle/10635/246758
dc.publisher	Taylor & Francis
dc.source	Taylor & Francis
dc.type	Article
dc.contributor.department	OBSTETRICS & GYNAECOLOGY
dc.description.doi	10.1080/14760584.2023.2239911
dc.description.sourcetitle	Expert Review of Vaccines
dc.description.volume	22
dc.description.issue	1
dc.description.page	696-703
dc.published.state	Published
Appears in Collections:	Elements Staff Publications

File	Description	Size	Format	Access Settings	Version
10.108014760584.2023.2239911.zip		1.4 MB	ZIP	OPEN	None	View/Download

Check